PMID: 6992903Apr 1, 1980

Clinical and pharmacokinetic factors affecting response to phenelzine

The British Journal of Psychiatry : the Journal of Mental Science
P TyrerM Whitford

Abstract

Sixty patients, 30 with depressive neurosis, 15 with anxiety neurosis and 15 with phobic anxiety states, were treated with the monoamine oxidase inhibitor, phenelzine, in two different dosage schedules for four weeks. All patients received an initial dose of 15 mg daily, increasing to 30 mg daily between the third and seventh day, but subsequently, using double-blind procedure, one group tooke the commonly prescribed dose of 45 mg daily and the other took 90 mg daily. Acetylator status was independently determined before the start of treatment. Each diagnostic group showed a similar response to treatment, but patients taking the higher dose improved significantly more than those taking normal dosage, and the rate of improvement, measured by weekly self-ratings, was also more rapid with higher dosage. Acetylator status did not affect clinical response. The results suggest that dosage is more important in determining clinical response to phenelzine in neurotic disorder than specific diagnosis or acetylator status.

References

Apr 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·P Tyrer
May 1, 1977·The British Journal of Psychiatry : the Journal of Mental Science·D M Shaw
Nov 25, 1978·Lancet·W J Tilstone, E C Johnstone
Feb 28, 1979·Psychopharmacology·W J TilstoneE C Johnstone
Nov 1, 1977·The British Journal of Psychiatry : the Journal of Mental Science·C Q MountjoyI M Leitch
May 1, 1978·American Journal of Surgery·B Satiani, E D Davidson
Sep 1, 1978·British Journal of Clinical Pharmacology·E F MarshallM Roth
May 1, 1978·Archives of General Psychiatry·D S RobinsonD Bartlett
Jun 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·E S PaykelE R Rassaby
Oct 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R S Hallam
Mar 1, 1976·Archives of General Psychiatry·C L RavarisL Korson
Oct 2, 1976·British Medical Journal·E F Marshall
Mar 17, 1973·Lancet·E C Johnstone, W Marsh
May 1, 1973·Clinical Pharmacology and Therapeutics·P Tyrer, M H Lader
Feb 1, 1973·Canadian Psychiatric Association Journal·L SolyomG Steinberg
Aug 1, 1972·The British Journal of Psychiatry : the Journal of Mental Science·K SchapiraC Gurney
Dec 1, 1969·Journal of Medical Genetics·D A Evans
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M HAMILTON
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
May 1, 1961·The Journal of Mental Science·E J NUFFIELD

Citations

Jan 1, 1989·European Archives of Psychiatry and Neurological Sciences·D F Klein, H M Klein
Jan 1, 1992·Psychopharmacology·F M Quitkin
May 4, 2005·European Archives of Psychiatry and Clinical Neuroscience·Mazda AdliMichael Bauer
Jan 1, 1988·Journal of Psychiatric Research·P Tyrer, C Shawcross
Apr 1, 1984·Journal of Affective Disorders·J DavidsonR Strickland
Sep 1, 1986·Journal of Affective Disorders·P Tyrer
Nov 24, 2004·Journal of Psychiatric Practice·Jess G Fiedorowicz, Karen L Swartz
Jun 8, 2002·Pharmacogenomics·Peter Meisel
Jan 1, 1984·Current Medical Research and Opinion·M Lader
Apr 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·P TyrerJ Gall
May 17, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Stephen C Mitchell
Sep 14, 2006·Pharmacological Reviews·Sharon J Gardiner, Evan J Begg
Jun 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·C M Pare
Jan 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·P Tyrer, S Murphy
Dec 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·F M Quitkin, D F Klein
Sep 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·E S PaykelR R Parker

Related Concepts

Anxiety States, Neurotic
Clinical Trials
Depressive Symptoms
Dose-Response Relationship, Drug
Double-Blind Method
Neurotic Disorders
Nardelzine
Phobia, Social

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.